Brief: Spark Therapeutics And Combigene Enter Into Exclusive, Global Licensing Agreement For Gene Therapy Candidate CG01
12/10/2021 13:07
Oct 12 (Reuters) - Combigene AB COMBI.ST :
* SPARK THERAPEUTICS AND COMBIGENE ENTER INTO EXCLUSIVE,
GLOBAL
LICENSING AGREEMENT FOR GENE THERAPY CANDIDATE CG01
* COMBIGENE AB - AGREEMENT PROVIDES SPARK WITH EXCLUSIVE,
WORLDWIDE LICENSE TO DEVELOP, MANUFACTURE AND COMMERCIALIZE CG01
* COMBIGENE AB - WILL CONTINUE TO EXECUTE CERTAIN ASPECTS OF
PRECLINICAL PROGRAM IN COLLABORATION WITH SPARK.
Source text for Eikon: ID:nGNX32Ybqb
Further company coverage: COMBI.ST
((Reuters.Briefs@thomsonreuters.com;))